Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Randomized Controlled Trial

Research Support, U.S. Gov't, P.H.S.

Clinical Trial

Research Support, Non-U.S. Gov't

Research Support, N.I.H., Extramural

Comparative Study

Meta-Analysis

Systematic Review

Clinical Trial, Phase II

Clinical Trial, Phase I

Multicenter Study

Publication Year

From

Quick links

Individual year

2024

2019

2017

2016

2015

2008

2005

2003

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Receptors, Opioid, kappa""[mesh_terms]

16 Results

Searching titles within these results

Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.

B E Lacy

Neurogastroenterology and motility 2016;28(1):26-35

Full Text

Abstract

Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.

A Gadano, R Moreau, F Pessione, C Trombino, N Giuily, P Sinnassamy, D Valla, D Lebrec

Journal of hepatology 2000;32(1):38-42

Full Text

Abstract

Docking and free energy perturbation studies of ligand binding in the kappa opioid receptor.

Dahlia A Goldfeld, Robert Murphy, Byungchan Kim, Lingle Wang, Thijs Beuming, Robert Abel, Richard A Friesner

The journal of physical chemistry. B 2015;119(3):824-35

Full Text

Abstract

Pharmacological interventions for pruritus in adult palliative care patients.

Waldemar Siemens, Carola Xander, Joerg J Meerpohl, Sabine Buroh, Gerd Antes, Guido Schwarzer, Gerhild Becker

The Cochrane database of systematic reviews 2016;11(11):CD008320

Free Full Text

Abstract

Pharmacological characterization of human kappa/mu opioid receptor chimeras that retain high affinity for dynorphin A.

Robert N DeHaven, Erik Mansson, Jeffrey D Daubert, Joel A Cassel

Current topics in medicinal chemistry 2005;5(3):303-13

Full Text

Abstract

The function of the extracellular regions in opioid receptor binding: insights from computational biology.

M Germana Paterlini

Current topics in medicinal chemistry 2005;5(3):357-67

Full Text

Abstract

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.

Silvia Delgado-Aros, Heather J Chial, Michael Camilleri, Lawrence A Szarka, Frank T Weber, Jutta Jacob, Irene Ferber, Sanna McKinzie, Duane D Burton, Alan R Zinsmeister

American journal of physiology. Gastrointestinal and liver physiology 2003;284(4):G558-66

Free Full Text

Abstract

NMR and modeling studies of a synthetic extracellular loop II of the kappa opioid receptor in a DPC micelle.

Li Zhang, Robert N DeHaven, Murray Goodman

Biochemistry 2002;41(1):61-8

Full Text

Abstract

Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.

H J Kramer, W Uhl, B Ladstetter, A Bäcker

British journal of clinical pharmacology 2000;50(3):227-35

Free Full Text

Abstract

Does environmental exposure to the greenhouse gas, NO, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence.

Keith Fluegge

Environmental toxicology and pharmacology 2017;47():6-18

Full Text

Abstract

Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.

Paola Casarosa, Anita K Nivedha, Christofer S Tautermann, Supriyo Bhattacharya, Sangbae Lee, Ines Kollak, Tobias Kiechle, Nagarajan Vaidehi

Molecular pharmacology 2019;93(4):288-296

Free Full Text

Abstract

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.

Rama Melkote, Wayne C Drevets, Mark E Schmidt, Maurizio Fava, Iva Kezic, Vanina Popova, Peter Van Der Ark, Darrel J Pemberton, Guy Mareels, Carla M Canuso

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2024;49(9):1437-1447

Free Full Text

Abstract

Uremic pruritus.

Thomas Mettang, Andreas E Kremer

Kidney international 2016;87(4):685-91

Free Full Text

Abstract

Uremic Itch Management.

Thomas Mettang

Current problems in dermatology 2017;50():133-41

Full Text

Abstract

Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.

Katia Varani, Stefania Gessi, Stefania Merighi, Valeria Iannotta, Elena Cattabriga, Susanna Spisani, Ruggero Cadossi, Pier Andrea Borea

British journal of pharmacology 2002;136(1):57-66

Free Full Text

Abstract

Results: 1 – 15 / 16

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Receptors, Opioid, kappa""[mesh_terms]

Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.

Aquaretic effects of niravoline, a kappa-opioid agonist, in patients with cirrhosis.

Docking and free energy perturbation studies of ligand binding in the kappa opioid receptor.

Pharmacological interventions for pruritus in adult palliative care patients.

Pharmacological characterization of human kappa/mu opioid receptor chimeras that retain high affinity for dynorphin A.

The function of the extracellular regions in opioid receptor binding: insights from computational biology.

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.

NMR and modeling studies of a synthetic extracellular loop II of the kappa opioid receptor in a DPC micelle.

Influence of asimadoline, a new kappa-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man.

Does environmental exposure to the greenhouse gas, NO, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence.

Identifying Functional Hotspot Residues for Biased Ligand Design in G-Protein-Coupled Receptors.

Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.

Uremic pruritus.

Uremic Itch Management.

Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.

Results for
""Receptors, Opioid, kappa""[mesh_terms]